| scholarly article | Q13442814 |
| P2093 | author name string | Stephen M Cohen | |
| George J Augustine | |||
| Pushpa Verma | |||
| Mohamed-Raafet Ammar | |||
| Ayumu Tashiro | |||
| P2860 | cites work | Drosophila as a model for human neurodegenerative disease | Q36312196 |
| VGLUTs: 'exciting' times for glutamatergic research? | Q36502195 | ||
| Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression | Q36609033 | ||
| The neuronal microRNA system | Q36657801 | ||
| Recombinase-mediated cassette exchange provides a versatile platform for gene targeting: knockout of miR-31b | Q37351843 | ||
| MicroRNAs in Alzheimer's disease | Q37979612 | ||
| MicroRNAs shape the neuronal landscape | Q38033846 | ||
| Chromosome 1p21.3 microdeletions comprising DPYD and MIR137 are associated with intellectual disability | Q38331099 | ||
| Visualizing glutamatergic cell bodies and synapses in Drosophila larval and adult CNS. | Q40119979 | ||
| Excitotoxicity and the NMDA receptor--still lethal after eight years | Q40400033 | ||
| Increased vesicular glutamate transporter expression causes excitotoxic neurodegeneration. | Q41597368 | ||
| An update on the potential role of excitotoxicity in the pathogenesis of Parkinson's disease | Q42869347 | ||
| Memantine in moderate-to-severe Alzheimer's disease | Q44388745 | ||
| Validation of schizophrenia-associated genes CSMD1, C10orf26, CACNA1C and TCF4 as miR-137 targets | Q45263643 | ||
| Evidence for increased expression of the vesicular glutamate transporter, VGLUT1, by a course of antidepressant treatment | Q46578570 | ||
| Bilateral enhancement of excitation via up-regulation of vesicular glutamate transporter subtype 1, not subtype 2, immunoreactivity in the unilateral hypoxic epilepsy model | Q46637630 | ||
| Protocols for use of homologous recombination gene targeting to produce microRNA mutants in Drosophila. | Q52717689 | ||
| Dynamic changes in vesicular glutamate transporter 1 function and expression related to methamphetamine-induced glutamate release | Q80507033 | ||
| Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression | Q24293587 | ||
| MicroRNA miR-137 regulates neuronal maturation by targeting ubiquitin ligase mind bomb-1 | Q24630616 | ||
| bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila | Q28131827 | ||
| Genome-wide association study identifies five new schizophrenia loci | Q28248384 | ||
| The conserved microRNA miR-8 tunes atrophin levels to prevent neurodegeneration in Drosophila | Q28252549 | ||
| A MicroRNA feedback circuit in midbrain dopamine neurons | Q28513149 | ||
| Pruning and loss of excitatory synapses by the parkin ubiquitin ligase | Q28576054 | ||
| Expression of the vesicular glutamate transporters during development indicates the widespread corelease of multiple neurotransmitters | Q28581851 | ||
| Sequence Relationships among C. elegans, D. melanogaster and Human microRNAs Highlight the Extensive Conservation of microRNAs in Biology | Q29013737 | ||
| A brain-specific microRNA regulates dendritic spine development | Q29614753 | ||
| Neurexin and neuroligin mediate retrograde synaptic inhibition in C. elegans | Q30448488 | ||
| miRNA malfunction causes spinal motor neuron disease | Q30495998 | ||
| MicroRNA-223 is neuroprotective by targeting glutamate receptors | Q30528539 | ||
| Glutamatergic alterations in the cortex of genetic absence epilepsy rats | Q33295364 | ||
| MicroRNAs in Parkinson's disease. | Q34247027 | ||
| The swiss cheese mutant causes glial hyperwrapping and brain degeneration in Drosophila. | Q34439060 | ||
| Vesicular glutamate transporters (VGLUTs): the three musketeers of glutamatergic system | Q34584131 | ||
| Ends-out, or replacement, gene targeting in Drosophila | Q34807177 | ||
| MicroRNA regulation of homeostatic synaptic plasticity | Q35105269 | ||
| MicroRNA-137/181c regulates serine palmitoyltransferase and in turn amyloid β, novel targets in sporadic Alzheimer's disease | Q35433358 | ||
| Dopamine-regulated microRNA MiR-181a controls GluA2 surface expression in hippocampal neurons | Q35697823 | ||
| Effects of chronic unpredictable stress and methamphetamine on hippocampal glutamate function | Q35728566 | ||
| Cause or Effect: Misregulation of microRNA Pathways in Neurodegeneration | Q35875886 | ||
| The microRNA miR-34 modulates ageing and neurodegeneration in Drosophila | Q35889746 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | microRNA | Q310899 |
| excitotoxicity | Q901117 | ||
| P304 | page(s) | 379-385 | |
| P577 | publication date | 2015-02-02 | |
| P1433 | published in | Nature Neuroscience | Q1535359 |
| P1476 | title | A neuroprotective role for microRNA miR-1000 mediated by limiting glutamate excitotoxicity | |
| P478 | volume | 18 |
| Q50015658 | A comprehensive review of the genetic and biological evidence supports a role for MicroRNA-137 in the etiology of schizophrenia. |
| Q36100164 | A let-7-to-miR-125 MicroRNA Switch Regulates Neuronal Integrity and Lifespan in Drosophila |
| Q28088777 | Drosophila as an In Vivo Model for Human Neurodegenerative Disease |
| Q35771016 | High Throughput Sequencing Identifies MicroRNAs Mediating α-Synuclein Toxicity by Targeting Neuroactive-Ligand Receptor Interaction Pathway in Early Stage of Drosophila Parkinson's Disease Model |
| Q92883362 | Identification of Cellular MicroRNA Coupling Strand Displacement Polymerization and Nicking-Endonuclease-Based Cleavage |
| Q52326263 | MIR137 schizophrenia-associated locus controls synaptic function by regulating synaptogenesis, synapse maturation and synaptic transmission. |
| Q38783698 | MicroRNA function in Drosophila melanogaster |
| Q37695394 | MicroRNA-92a is a circadian modulator of neuronal excitability in Drosophila |
| Q39414160 | MicroRNAs in neural development: from master regulators to fine-tuners |
| Q33880030 | Pervasive Behavioral Effects of MicroRNA Regulation in Drosophila |
| Q55334287 | Stroke recovery and rehabilitation in 2016: a year in review of basic science and clinical science. |
| Q92065725 | Synaptic and brain-expressed gene sets relate to the shared genetic risk across five psychiatric disorders |
| Q99350078 | The conserved microRNA miR-210 regulates lipid metabolism and photoreceptor maintenance in the Drosophila retina |
| Q89926621 | The conserved microRNA miR-34 regulates synaptogenesis via coordination of distinct mechanisms in presynaptic and postsynaptic cells |
| Q38879224 | The interplay of microRNAs and post-ischemic glutamate excitotoxicity: an emergent research field in stroke medicine |
| Q41693925 | The role of glutamate transporters in the pathophysiology of neuropsychiatric disorders |
| Q64062508 | Therapeutic Potential of Extracellular Vesicles for the Treatment of Nerve Disorders |
| Q36156512 | miR-27b shapes the presynaptic transcriptome and influences neurotransmission by silencing the polycomb group protein Bmi1 |
| Q92187683 | miRNA-Dependent Control of Homeostatic Plasticity in Neurons |
| Q39196300 | miRNAs in synapse development and synaptic plasticity |
Search more.